We were so close to having an encore of the picture-perfect results we got in Microsoft’s prior quarter.
Kategorie-Archiv: CNBC Financial News
Starbucks‘ turnaround takes an encouraging step forward. Here’s what we want to see next
Starbucks has a long way to go in its turnaround, but Tuesday night’s better-than-feared results are an encouraging step forward.
AMD jumps on earnings report that validates our decision to reinvest in the stock
AMD shares are getting a much-needed lift after the chipmaker upped the forecast for its AI business.
Bill Ackman seeking to raise $2 billion in Pershing Square fund IPO, lower than original expectations
The Pershing Square USA IPO will be in the form of a closed-end fund, and is expected to hold many of the same positions as Ackman’s other vehicles.
New Vanguard CEO says improving customer experience is a ‚very high‘ priority and AI could help
Salim Ramji comes to Vanguard from rival BlackRock, making him the first outsider CEO for the roughly $9 trillion asset manager.
Warren Buffett’s Berkshire Hathaway sells Bank of America for a ninth-straight day
Over the past nine trading sessions, Berkshire has cut its BofA stake by 71.2 million shares with just over $3 billion of sales.
Russia considers legalizing crypto for global payments as it faces ongoing sanctions
Russia’s parliament will consider a law that permits international payments via cryptocurrencies, Russia’s central bank governor said.
Procter & Gamble earnings beat estimates, but quarterly sales disappoint as China demand slides
Procter & Gamble reported better-than-expected earnings, but its quarterly revenue fell short of Wall Street’s estimates.
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
The results come as Pfizer scrambles to stabilize its business and win back Wall Street’s favor following the rapid decline in demand for its Covid products.
Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
The drugmaker raised its full-year sales forecast to $63.4 billion to $64.4 billion on increased demand for key products, particularly oncology treatments.